Evaluating the relationship between time-normalized relative value unit assignment and complication rates across specialties: Is urology undercompensated?

by L. Haeuser, E.B. Cone, S. Reese, M. Marchese, M. Paciotti, Q. Trinh
Published 2020-07-01

Impact of facility volume on complications from immunotherapy for renal cell carcinoma

by M. Paciotti, E.B. Cone, L. Haeuser, Y. Wang, S.L. Chang
Published 2020-07-01

Trends in ambulatory prescribing of fluoroquinolones following United States Food and Drug Administration adverse effect warnings in 2008 and 2013

by D.F. Friedlander, D. Modonutti, E.B. Cone, Y. Wang, S. Chang, Q. Trinh
Published 2020-07-01

Comparison of surgical complications requiring intervention in open vs. minimally invasive radical prostatectomy

by L. Haeuser, M. Paciotti, S. Reese, R.D. Urman, J. Noldus, E.B. Cone
Published 2020-07-01

Checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

by E.B. Cone, L. Haeuser, S. Reese, M. Marchese, J. Nabi, F. Abdollah, K. Kilbridge, Q. Trinh
Published 2020-07-01

Abiraterone is associated with higher odds of cardiac complications compared to enzalutamide

by E.B. Cone, D. Modonutti, S. Reese, M. Marchese, J. Nabi, F. Abdollah, K. Kilbridge, Q-D. Trinh
Published 2020-07-01

Lower odds of cardiac events for gonadotropic releasing hormone antagonists versus agonists

by E.B. Cone, D. Modonutti, S. Reese, M. Marchese, J. Nabi, F. Abdollah, K. Kilbridge, Q-D. Trinh
Published 2020-07-01

Do delays in prostate cancer treatment change survival outcomes?

by M. Paciotti, E.B. Cone, M. Marchese, D. Nguyen, A.P. Cole, L.A. Mucci, A.R. Saita, M. Lazzeri, N.M. Buffi, G. Lughezzani, A.S. Kibel, Q. Trinh
Published 2020-10-01